Literature DB >> 15906752

The role of (duodeno)gastroesophagopharyngeal reflux in unexplained excessive throat phlegm.

J Poelmans1, L Feenstra, J Tack.   

Abstract

Gastroesophageal reflux (GER), through the occurrence of gastroesophagopharyngeal reflux (GEPR), is an established cause of several otorhinolaryngological (ORL) manifestations. It has been suggested that unexplained excessive throat phlegm might also be a manifestation of GER, but formal evidence is lacking. The aim of the present study was to investigate the prevalence of GER as well as duodenogastroesophageal reflux (DGER) in consecutive patients with chronic complaints of excessive throat phlegm. Fifty-nine consecutive patients with chronic unexplained excessive throat phlegm, transparent in 33 patients (TTP) and yellow in 26 patients (YTP), underwent gastrointestinal endoscopy, 24-hr dual esophageal pH monitoring, and fiberoptic DGER monitoring. Proximal esophageal DGER monitoring was performed in seven YTP patients and analysis of bile acids in throat phlegm was performed on 16 samples. The effect of high-dose acid suppressive therapy was evaluated at 2-week intervals. Endoscopy and pH monitoring established a diagnosis of pathological GER in 75% of the patients. Pathological DGER was present in 56% of the patients and this was associated with YTP. Proximal DGER exposure was high in all investigated subjects and chemical analysis revealed a median bile acid concentration of 0.184 microM in nine YTP samples and no detectable bile acids in seven TTP samples. After a median of 4 weeks of acid suppressive therapy, most patients improved and 61% became asymptomatic. YTP patients were more likely to require maintenance acid suppressive therapy than TTP patients. Unexplained excessive throat phlegm is a sign suggestive of GER and GEPR, and unexplained yellow throat phlegm a sign suggestive of duodenogastroesophagopharyngeal reflux (DGEPR).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15906752     DOI: 10.1007/s10620-005-2647-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  37 in total

1.  Prospective study on the incidence of chronic ear complaints related to gastroesophageal reflux and on the outcome of antireflux therapy.

Authors:  Johan Poelmans; Jan Tack; Louw Feenstra
Journal:  Ann Otol Rhinol Laryngol       Date:  2002-10       Impact factor: 1.547

2.  Intrapharyngeal distribution of gastric acid refluxate.

Authors:  Reza Shaker; Eytan Bardan; Chengming Gu; Mark Kern; Laura Torrico; Robert Toohill
Journal:  Laryngoscope       Date:  2003-07       Impact factor: 3.325

3.  Effect of sleep, spontaneous gastroesophageal reflux, and a meal on upper esophageal sphincter pressure in normal human volunteers.

Authors:  P J Kahrilas; W J Dodds; J Dent; B Haeberle; W J Hogan; R C Arndorfer
Journal:  Gastroenterology       Date:  1987-02       Impact factor: 22.682

4.  Autonomic dysfunction, vasomotor rhinitis, and extraesophageal manifestations of gastroesophageal reflux.

Authors:  Todd A Loehrl; Timothy L Smith; Ronald J Darling; Laura Torrico; Thomas E Prieto; Reza Shaker; Robert J Toohill; Safwan S Jaradeh
Journal:  Otolaryngol Head Neck Surg       Date:  2002-04       Impact factor: 3.497

5.  Gastroesophageal reflux and eustachian tube dysfunction in an animal model.

Authors:  David R White; S Brett Heavner; Stuart M Hardy; Jiri Prazma
Journal:  Laryngoscope       Date:  2002-06       Impact factor: 3.325

6.  Characteristics and clinical relevance of proximal esophageal pH monitoring.

Authors:  Mike Cool; Johan Poelmans; Louw Feenstra; Jan Tack
Journal:  Am J Gastroenterol       Date:  2004-12       Impact factor: 10.864

7.  Gastroesophageal reflux in patients with asthma and chronic bronchitis.

Authors:  A Ducoloné; A Vandevenne; H Jouin; J C Grob; D Coumaros; C Meyer; G Burghard; G Methlin; L Hollender
Journal:  Am Rev Respir Dis       Date:  1987-02

8.  Laryngopharyngeal manifestations of gastroesophageal reflux disease.

Authors:  N R Olson
Journal:  Otolaryngol Clin North Am       Date:  1991-10       Impact factor: 3.346

9.  Gastroesophageal reflux as an etiologic factor in laryngeal complications of intubation.

Authors:  E B Gaynor
Journal:  Laryngoscope       Date:  1988-09       Impact factor: 3.325

10.  Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both?

Authors:  J Tack; G Koek; I Demedts; D Sifrim; J Janssens
Journal:  Am J Gastroenterol       Date:  2004-06       Impact factor: 10.864

View more
  3 in total

Review 1.  Extraoesophageal manifestations of gastro-oesophageal reflux.

Authors:  J Poelmans; J Tack
Journal:  Gut       Date:  2005-10       Impact factor: 23.059

2.  Paroxysmal laryngospasm: a typical but underrecognized supraesophageal manifestation of gastroesophageal reflux?

Authors:  Johan Poelmans; Jan Tack; Louw Feenstra
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

3.  Determinants of long-term outcome of patients with reflux-related ear, nose, and throat symptoms.

Authors:  Johan Poelmans; Louw Feenstra; Jan Tack
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.